Yuzaburo Shimizu

Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.

Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.

Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.

Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells.

Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.